Peter Sejer Andersen
Overview
Explore the profile of Peter Sejer Andersen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stranzl T, Bernstein D, Matsuoka T, Durham S, Maekawa Y, Sejer Andersen P, et al.
Allergy Asthma Proc
. 2024 May;
45(4):232-239.
PMID: 38760164
The clinical development program of the SQ grass, ragweed, tree, and house dust mite (HDM) sublingual immunotherapy (SLIT)-tablets for allergic rhinitis/conjunctivitis (AR/C) included clinical trials conducted in North America, Europe,...
2.
Hoof I, Bonnelykke K, Stranzl T, Brand S, Li X, Shamji M, et al.
Thorax
. 2023 Dec;
79(4):332-339.
PMID: 38160049
Background: Hypersensitivity to house dust mite (HDM) allergens is a common cause of allergic asthma symptoms and can be effectively treated with allergy immunotherapy (AIT). Objective: To investigate whether genetic...
3.
Lund G, Christensen L, Ihlemann J, Sejer Andersen P, Wambre E, Wurtzen P, et al.
Front Immunol
. 2023 Dec;
14:1291666.
PMID: 38077382
Background: Allergens from Fagales trees frequently cause spring allergy in Europe, North America, and some parts of Asia. The definition of the birch homologous group, which includes birch (Bet v),...
4.
Wurtzen P, Gronager P, Lund G, Gupta S, Sejer Andersen P, Biedermann T, et al.
Clin Exp Allergy
. 2020 Nov;
51(2):284-295.
PMID: 33207015
Background: The SQ tree SLIT-tablet (containing birch extract) proved clinically significant effects during the pollen season for birch as well as alder/hazel. Immune outcomes of this treatment for allergens from...
5.
Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study
Stranzl T, Ipsen H, Christensen L, Eiwegger T, Johansen N, Lund K, et al.
Allergy
. 2020 Jan;
76(4):1235-1238.
PMID: 31989625
No abstract available.
6.
Hagner S, Rask C, Brimnes J, Sejer Andersen P, Raifer H, Renz H, et al.
Int Arch Allergy Immunol
. 2016 Jun;
170(1):22-34.
PMID: 27287860
Background: Evidence regarding sublingual immunotherapy (SLIT) efficacy and its good safety profile has been demonstrated with pollen and house dust mite (HDM) allergens in the treatment of airway allergies. In...
7.
Steveling E, Lao-Araya M, Koulias C, Scadding G, Eifan A, James L, et al.
Clin Transl Allergy
. 2015 Dec;
5:43.
PMID: 26682038
Background: Seasonal Allergic Rhinitis is characterised by inflammation of the nasal mucosa upon exposure to common aeroallergens, affecting up to 20-25 % of the population. For those patients whose symptoms...
8.
Koefoed K, Steinaa L, Soderberg J, Kjaer I, Jacobsen H, Meijer P, et al.
MAbs
. 2011 Nov;
3(6):584-95.
PMID: 22123060
The epidermal growth factor receptor (EGFR) is frequently dysregulated in human malignancies and a validated target for cancer therapy. Two monoclonal anti-EGFR antibodies (cetuximab and panitumumab) are approved for clinical...